Industry Information

Update August 01, 2021

Gilead’s latest financial report: Remdesivir’s Q2 revenue exceeds US$800 million, and CAR-T therapy has increased significantly

On July 29, local time, Gilead Sciences (GILD.US) released its financial report for the second quarter ending June 30, 2021. The financial report shows that Gilead’s Q2 total revenue was US$6.217...

Update July 30, 2021

Two new drugs are planned to be included in the priority review, from Betta Pharmaceuticals and Cinda Bio

According to the latest announcement from the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China, two new drugs are planned to be included in priority review,...

Update July 24, 2021

Top ten pharmaceutical companies have been approved for new drug ranking in five years! Novartis topped the list, Roche and Eli Lilly received performance boosts; AbbVie, BMS...

The approval of new drugs is the holy grail for large and small pharmaceutical companies, and the track record of bringing new drugs to the market is one of the ultimate tests of R&D strength,...

Update July 23, 2021

Over 60 new drugs have been approved for clinical use, and the outbreak of bispecific antibodies is imminent?

In recent years, global bispecific antibodies have been growing rapidly in the preclinical and clinical stages. Up to now, 4 dual-antibody drugs have been marketed worldwide, two of which have been...

Update July 21, 2021

Loss for 10 years, but turned the loss into profit with "one shot"

Over the weekend, Cansino announced the performance forecast for the first half of 2021. During the period, it is expected to realize operating income of 2-2 billion yuan (49532.59%-54495.85%); net...

Update July 20, 2021

[Yao Kajun] 26 new drugs have been approved for clinical use, and the popular targets continue to rise. Hengrui, Betta...

Yaozhi data shows that in this period (July 9 to July 16), 26 new drugs were approved clinically (32 acceptance numbers); another 41 varieties (52 acceptance numbers) clinical applications were...

Update July 19, 2021

Frontier | Research progress of kinase inhibitors in the treatment of coronavirus infections

As of now, the cumulative number of COVID-19 infections worldwide has exceeded 187 million, and about 4 million have died (Figure 1). Although relevant vaccines have already been put into...

Update July 17, 2021

Hengrui's Class 1 new drug SHR3680 in the treatment of stage III prostate cancer reaches the primary research endpoint

Recently, Hengrui Medicine's Class 1 new drug SHR3680 combined with androgen deprivation therapy (ADT) compared to standard therapy combined with ADT for the treatment of high tumor burden metastatic...

Update July 16, 2021

15 blockbuster drugs expire patents! BMS accounted for 3 models, Merck & Co., Ltd. 2 models, AbbVie, Novartis, Pfizer...

In 10 years, the situation is changing, and the pharmaceutical field will also undergo significant changes. In particular, a batch of super "blockbusters" will fall off the cliff of patents. This...

Update July 15, 2021

In-depth | One article to understand the progress of domestic lung cancer targeted therapy

Overview of Lung Cancer (1) Definition of lung cancer Primary bronchial lung cancer, referred to as lung cancer, originates from the trachea, bronchial mucosa or glands, and is the most common...